ISIN | CH0482324271 |
---|---|
Valor Number | 48232427 |
Bloomberg Global ID | |
Fund Name | Credit Suisse (CH) Privilege 45 CHF IA25 |
Fund Provider |
UBS Asset Management Switzerland AG, Zurich
8098 Zürich, Schweiz E-Mail: ubs-am-wholesale-switzerland@ubs.com Web: www.ubs.com/fonds |
Fund Provider | UBS Asset Management Switzerland AG, Zurich |
Representative in Switzerland | |
Distributor(s) | |
Asset Class | Asset Allocation |
EFC Category | |
Distribution Policy | Distribution |
Home Country | Switzerland |
Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | The Fund invests in equities, bonds, and money market instruments worldwide. In so doing, it adheres to the provisions of the Federal Law on Occupational Old Age, Survivors and Disability Pension Plans (BVG) and the relevant regulations (BVV2 and BVV3) governing investments. The Fund distributes its earnings. |
Peculiarities |
Current Price * | 1,112.28 CHF | 01.04.2025 |
---|---|---|
Previous Price * | 1,108.93 CHF | 31.03.2025 |
52 Week High * | 1,148.82 CHF | 13.02.2025 |
52 Week Low * | 1,051.16 CHF | 19.04.2024 |
NAV * | 1,112.28 CHF | 01.04.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 1,310,163,215 | |
Unit/Share Assets *** | 232,198,618 | |
Trading Information SIX |
YTD Performance | -0.21% |
30.12.2024 - 01.04.2025
30.12.2024 01.04.2025 |
---|---|---|
1 month | -2.63% |
03.03.2025 - 01.04.2025
03.03.2025 01.04.2025 |
3 months | -0.47% |
03.01.2025 - 01.04.2025
03.01.2025 01.04.2025 |
6 months | +0.88% |
01.10.2024 - 01.04.2025
01.10.2024 01.04.2025 |
1 year | +3.91% |
02.04.2024 - 01.04.2025
02.04.2024 01.04.2025 |
2 years | +10.50% |
03.04.2023 - 01.04.2025
03.04.2023 01.04.2025 |
3 years | +2.16% |
01.04.2022 - 01.04.2025
01.04.2022 01.04.2025 |
5 years | +21.72% |
01.04.2020 - 01.04.2025
01.04.2020 01.04.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
UBS ETF MSCI USA Selection USD A-acc | 10.70% | |
---|---|---|
UBS ETF S&P 500 Scored & Scrn USD A-acc | 5.43% | |
Nestle SA | 2.83% | |
Novartis AG Registered Shares | 2.67% | |
Roche Holding AG | 2.60% | |
CSIF (Lux) Equity EmMkts ESG Blue QBXUSD | 2.42% | |
UBS (CH) IF - Eq CH All ESG NSL I-A-acc | 2.34% | |
UBS Group AG | 1.44% | |
Compagnie Financiere Richemont SA Class A | 1.34% | |
CSIF (Lux) Equity Japan ESG Blue QBX JPY | 1.34% | |
Last data update | 31.01.2025 |
TER | 0.47% |
---|---|
TER date | 31.12.2023 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.80% |
Ongoing Charges *** | 0.47% |
SRRI ***
|
|
SRRI date *** | 28.02.2025 |